valproic acid has been researched along with ex 527 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dargatz, H; Fahr, A; Heinzel, T; Hennig, D; Imhof, D; Kostenis, E; Schubert, S; Schubert, US | 1 |
| Chung, RS; Cole, NJ; De Luca, A; Guillemin, GJ; Laird, AS; Lee, A; Luu, L; Nicholson, GA; Robinson, KJ; Suddull, HJ; Tym, MC; Watchon, M; Yuan, KC | 1 |
2 other study(ies) available for valproic acid and ex 527
| Article | Year |
|---|---|
Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors.
Topics: Acetylation; Angiotensin II; Carbazoles; Dextrans; Drug Carriers; HEK293 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lactic Acid; Liposomes; Nanoparticles; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sirtuin 1; Valproic Acid | 2014 |
Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo.
Topics: Acetylation; Animals; Animals, Genetically Modified; Ataxin-3; Autophagy; Carbazoles; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Genes, Reporter; HEK293 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Machado-Joseph Disease; Peptides; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Repressor Proteins; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Swimming; Trinucleotide Repeat Expansion; Valproic Acid; Zebrafish; Zebrafish Proteins | 2021 |